Samsara
Valuation each multiple against its own 5-year range
Vs. peers Software - Infrastructure
| Company | Market cap | P/E (TTM)i | P/Bi | Div yieldi |
|---|---|---|---|---|
| Samsara (IOT) | 21.95B | 249.93 | 13.70 | 0.00% |
| Microsoft (MSFT) | 3.60T | 25.30 | 7.65 | 0.75% |
| Palantir (PLTR) | 345.74B | 101.05 | 30.79 | 0.00% |
| Oracle (ORCL) | 305.97B | 15.86 | 4.95 | 1.98% |
| Palo Alto Networks (PANW) | 281.87B | 686.64 | 9.83 | 0.00% |
| CrowdStrike (CRWD) | 234.93B | 6,037.89 | 46.05 | 0.00% |
Other StockVane-tracked companies in the same industry.
Morningstar
Trading 12.2% below Morningstar's fair value estimate.
Fair value
Samsara Inc earns a 3-star quantitative star rating, illustrating our stance that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a 9% discount to our quantitative fair value estimate of $42.08 per share; however, caution is warranted due to this estimate's high uncertainty rating.
The company's solid growth increases our quantitative valuation. Consistent revenue and earnings growth indicates a company's potential for increased market share and profitability. Reflecting the firm's growth is its revenue 3-year growth of 32.6%, which falls in the top 10% compared with peers globally. Robust trailing three-year revenue growth portends a favorable future trajectory, which contributes to our view that shares are cheap.
Alternatively, the company's lack of profitability is potentially concerning. Companies with low profitability are often less resilient in recessions and are likely to generate weaker future cash flows for shareholders. The firm's sales yield of 7.7%, for example, ranks in the bottom 10% compared with peers globally. This company's inability to generate significant sales growth without meaningful capital investment is a challenge, which, despite our favorable price/fair value ratio, is a negative attribute.
Economic moat
The narrow moat rating for this company indicates investors can expect it to generate 10 years or more of excess returns on capital due to its respectable competitive advantages. In addition, the company's moderate financial health score is decent and doesn't seriously concern us with regard to financial distress.
By Quantitative Equity Report
Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.
Samsara discussion 0 comments